Stock Events

Stock Events

Xilio Therapeutics (XLO) Q2 2026 Earnings

12MayConfirmed

Q2 2025

Q3 2025

Q4 2025

Q2 2026

-1.54

-1.05

-0.57

-0.08

Details

Expected EPS

-0.66

Actual EPS

-0.58

Surprise EPS

0.08

Surprise Percent

+12.12%

Description

Xilio Therapeutics (XLO) has reported earnings of -0.58 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.